Bayer keeps benefiting from euro weakness: report

BERLIN (Reuters) – German pharmaceuticals group Bayer keeps benefiting from the weak euro, though the region’s deepening debt crisis is beginning to weigh on orders in some sectors, a Swiss newspaper reported, citing the group’s chief financial officer.